Introducing NEJM Evidence
Launching January 2022, NEJM Evidence, a new monthly digital journal from NEJM Group, presents innovative original research and fresh, bold ideas in clinical trial design and clinical decision-making.
The volume of clinical research continues to grow, yet the standards to establish and validate claims, especially as related to clinical practice, have not followed suit. NEJM Evidence expands the corpus of published research with a focus on providing more context and critical evaluation of the methods and results to support clinical decision-making, and does so in a way that respects the time and commitment of the practitioner.
Taking a new approach, NEJM Evidence offers a behind-the-scenes view of clinical trials that enables readers to develop a deeper understanding of the statistical methods used in trials, to become more sophisticated evaluators of medical evidence, and to learn from trial participants whose stories can help shape and inform the future direction of clinical trial design.